Varex Imaging (NASDAQ:VREX) Upgraded to "Strong-Buy" at B. Riley

Varex Imaging (NASDAQ:VREX - Get Free Report) was upgraded by equities researchers at B. Riley to a "strong-buy" rating in a research note issued on Monday,Zacks.com reports. B. Riley also issued estimates for Varex Imaging's Q1 2026 earnings at $0.08 EPS and Q3 2026 earnings at $0.11 EPS.

Several other research analysts also recently weighed in on the stock. StockNews.com upgraded shares of Varex Imaging from a "hold" rating to a "buy" rating in a research note on Friday, February 7th. Oppenheimer lowered their target price on shares of Varex Imaging from $30.00 to $23.00 and set an "outperform" rating on the stock in a research note on Friday, February 7th.

Varex Imaging Stock Performance

Shares of VREX stock opened at $7.52 on Monday. The firm's 50 day moving average price is $9.76 and its 200-day moving average price is $12.67. The company has a debt-to-equity ratio of 1.02, a quick ratio of 2.50 and a current ratio of 4.36. Varex Imaging has a one year low of $6.76 and a one year high of $16.93. The firm has a market cap of $309.82 million, a P/E ratio of -6.43 and a beta of 0.62.

Varex Imaging (NASDAQ:VREX - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported $0.26 EPS for the quarter, beating analysts' consensus estimates of $0.14 by $0.12. The firm had revenue of $212.90 million for the quarter, compared to the consensus estimate of $206.76 million. Varex Imaging had a negative net margin of 5.79% and a positive return on equity of 4.00%. The company's revenue was up 3.3% on a year-over-year basis. During the same period last year, the firm posted $0.16 EPS. As a group, equities research analysts predict that Varex Imaging will post 0.53 EPS for the current year.

Insider Buying and Selling at Varex Imaging

In related news, SVP Kimberley E. Honeysett sold 4,007 shares of the stock in a transaction that occurred on Thursday, March 20th. The shares were sold at an average price of $12.81, for a total value of $51,329.67. Following the sale, the senior vice president now directly owns 4,002 shares in the company, valued at $51,265.62. This trade represents a 50.03% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Sunny Sanyal sold 8,749 shares of the business's stock in a transaction that occurred on Wednesday, April 2nd. The shares were sold at an average price of $11.24, for a total transaction of $98,338.76. Following the transaction, the chief executive officer now owns 190,193 shares of the company's stock, valued at approximately $2,137,769.32. This represents a 4.40% decrease in their position. The disclosure for this sale can be found here. Insiders own 4.30% of the company's stock.

Institutional Investors Weigh In On Varex Imaging

A number of institutional investors and hedge funds have recently modified their holdings of VREX. Barclays PLC boosted its position in shares of Varex Imaging by 15.3% during the 3rd quarter. Barclays PLC now owns 97,883 shares of the company's stock worth $1,166,000 after acquiring an additional 12,966 shares in the last quarter. Principal Financial Group Inc. raised its stake in Varex Imaging by 10.5% during the fourth quarter. Principal Financial Group Inc. now owns 41,144 shares of the company's stock worth $600,000 after buying an additional 3,914 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. raised its stake in Varex Imaging by 87.1% during the fourth quarter. Connor Clark & Lunn Investment Management Ltd. now owns 49,030 shares of the company's stock worth $715,000 after buying an additional 22,829 shares during the last quarter. Proficio Capital Partners LLC bought a new position in Varex Imaging during the fourth quarter worth $426,000. Finally, Cerity Partners LLC bought a new stake in Varex Imaging in the fourth quarter valued at $147,000.

About Varex Imaging

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.